ResMed [RMD] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
ResMed
NYSE
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: ResMed wins in 14 metrics, Intuitive Surgical wins in 5 metrics, with 0 ties. ResMed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | ResMed | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.93 | 67.08 | ResMed |
| Price-to-Book Ratio | 6.99 | 9.65 | ResMed |
| Debt-to-Equity Ratio | 14.27 | 0.00 | Intuitive Surgical |
| PEG Ratio | 27.69 | 2.76 | Intuitive Surgical |
| EV/EBITDA | 22.23 | 52.40 | ResMed |
| Profit Margin (TTM) | 27.22% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 33.87% | 30.47% | ResMed |
| EBITDA Margin (TTM) | 33.87% | 30.47% | ResMed |
| Return on Equity | 25.86% | 16.04% | ResMed |
| Return on Assets (TTM) | 14.02% | 9.02% | ResMed |
| Free Cash Flow (TTM) | $1.65B | $1.30B | ResMed |
| Dividend Yield | 0.63% | N/A | N/A |
| 1-Year Return | 26.21% | -1.51% | ResMed |
| Price-to-Sales Ratio (TTM) | 8.11 | 18.83 | ResMed |
| Enterprise Value | $41.35B | $166.94B | Intuitive Surgical |
| EV/Revenue Ratio | 8.04 | 18.26 | ResMed |
| Gross Profit Margin (TTM) | 60.84% | 66.31% | Intuitive Surgical |
| Revenue per Share (TTM) | $35 | $26 | ResMed |
| Earnings per Share (Diluted) | $9.52 | $7.16 | ResMed |
| Beta (Stock Volatility) | 0.77 | 1.60 | ResMed |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
ResMed vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| ResMed | -0.03% | 0.97% | 9.56% | 12.90% | 21.97% | 25.19% |
| Intuitive Surgical | -0.43% | 0.21% | -7.15% | -14.68% | -21.25% | -8.55% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| ResMed | 26.21% | 29.34% | 58.71% | 445.15% | 835.08% | 1,478.59% |
| Intuitive Surgical | -1.51% | 127.01% | 97.74% | 738.64% | 1,479.43% | 5,823.36% |
Performance & Financial Health Analysis: ResMed vs Intuitive Surgical
| Metric | RMD | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $41.71B | $172.16B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,089,630 | 1,853,870 |
| 90 Day Avg. Volume | 1,052,930 | 2,048,940 |
| Last Close | $286.04 | $479.20 |
| 52 Week Range | $199.92 - $293.08 | $425.00 - $616.00 |
| % from 52W High | -2.40% | -22.21% |
| All-Time High | $301.34 (Sep 06, 2021) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -5.08% | -22.21% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.21% |
| Quarterly Earnings Growth | 0.30% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.27% | 0.29% |
| Operating Margin (TTM) | 0.34% | 0.30% |
| Return on Equity (TTM) | 0.26% | 0.16% |
| Debt to Equity (MRQ) | 14.27 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $40.77 | $49.79 |
| Cash per Share (MRQ) | $8.26 | $14.86 |
| Operating Cash Flow (TTM) | $1.75B | $2.83B |
| Levered Free Cash Flow (TTM) | $1.21B | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.63% | N/A |
| Last 12-Month Dividend | $1.59 | N/A |
Valuation & Enterprise Metrics Analysis: ResMed vs Intuitive Surgical
| Metric | RMD | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.93 | 67.08 |
| Forward P/E | 27.69 | 61.10 |
| PEG Ratio | 27.69 | 2.76 |
| Price to Sales (TTM) | 8.11 | 18.83 |
| Price to Book (MRQ) | 6.99 | 9.65 |
| Market Capitalization | ||
| Market Capitalization | $41.71B | $172.16B |
| Enterprise Value | $41.35B | $166.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.04 | 18.26 |
| Enterprise to EBITDA | 22.23 | 52.40 |
| Risk & Other Metrics | ||
| Beta | 0.77 | 1.60 |
| Book Value per Share (MRQ) | $40.77 | $49.79 |
Financial Statements Comparison: ResMed vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RMD | ISRG |
|---|---|---|
| Revenue/Sales | $1.35B | $2.44B |
| Cost of Goods Sold | $527.93M | $822.10M |
| Gross Profit | $820.07M | $1.62B |
| Research & Development | $86.44M | $313.30M |
| Operating Income (EBIT) | $456.57M | $743.40M |
| EBITDA | $532.89M | $898.70M |
| Pre-Tax Income | $458.05M | $832.10M |
| Income Tax | $78.35M | $167.90M |
| Net Income (Profit) | $379.71M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RMD | ISRG |
|---|---|---|
| Cash & Equivalents | $1.21B | $2.57B |
| Total Current Assets | $3.51B | $7.66B |
| Total Current Liabilities | $1.02B | $1.54B |
| Long-Term Debt | $811.41M | N/A |
| Total Shareholders Equity | $5.97B | $17.21B |
| Retained Earnings | $6.08B | $7.14B |
| Property, Plant & Equipment | $288.62M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RMD | ISRG |
|---|---|---|
| Operating Cash Flow | $441.40M | $833.10M |
| Capital Expenditures | $-30.59M | $-116.60M |
| Free Cash Flow | $504.99M | $465.00M |
| Debt Repayment | $-5.00M | N/A |
| Common Stock Repurchase | $-100.01M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | RMD | ISRG |
|---|---|---|
| Shares Short | 9.02M | 4.30M |
| Short Ratio | 9.55 | 2.18 |
| Short % of Float | 0.07% | 0.01% |
| Average Daily Volume (10 Day) | 1,089,630 | 1,853,870 |
| Average Daily Volume (90 Day) | 1,052,930 | 2,048,940 |
| Shares Outstanding | 146.39M | 356.60M |
| Float Shares | 145.49M | 356.33M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.65% | 0.89% |
Dividend Analysis & Yield Comparison: ResMed vs Intuitive Surgical
| Metric | RMD | ISRG |
|---|---|---|
| Last 12-Month Dividend | $1.59 | N/A |
| Last 12-Month Dividend Yield | 0.63% | N/A |
| 3-Year Avg Annual Dividend | $1.60 | N/A |
| 3-Year Avg Dividend Yield | 0.23% | N/A |
| 3-Year Total Dividends | $4.79 | N/A |
| Ex-Dividend Date | Feb 13, 2025 | N/A |